Eric H. Wexler, Partner, Private Equity Transactions

Eric H. Wexler

Partner

Areas of Focus

Eric H. Wexler, Partner, Private Equity Transactions

Eric H. Wexler

Partner

ewexler@akingump.com

Areas of Focus

Save as PDF

Share This Biography

LinkedIn

Biography
  • Advises investment funds, family offices and corporate clients in connection with mergers & acquisitions, portfolio investments, reorganizations and fund structuring.

Eric has a diverse corporate practice focusing on mergers & acquisitions (M&A), portfolio investments, reorganizations and fund structuring. In particular, he advises on public and private M&A and divestitures, joint ventures (JV), private equity transactions, fund and corporate restructurings, competitive auctions, asset purchases & sales, transactions involving complex partnership structures, preferred equity investments, initial public offerings (IPOs) and debt financings.

Eric’s strategic advice combines a sophisticated understanding of tax structuring and corporate law matters, often involving significant cross-jurisdictional elements. He works across a wide range of industries, including emerging technologies and life sciences.

Prior to joining Akin, Eric practiced in the New York office of another leading international law firm.

Representative Work
  • Represented OpenAI in its multiyear, multibillion-dollar investment from Microsoft. The investment allows OpenAI to continue its development of artificial intelligence (AI).
  • Advised small satellites innovator Terran Orbital Corporation in the $1.6-billion business combination with Tailwind Two Acquisition Corp. Terran Orbital is a leading small satellite manufacturer primarily serving the U.S. aerospace & defense industry.
  • Represented ProKidney in its $2.64-billion business combination with Social Capital Suvretta Holdings Corp. III. ProKidney is a leading clinical-stage cellular therapeutics company focused on chronic kidney disease.
  • Represented Royalty Pharma on its $2.5-billion IPO and listing on the Nasdaq Global Select Market.
  • Represented a medical device technology company in a $500-million funding round that valued the business at an $800-million post-money valuation. The funding round included participation by more than 50 investors, including leading family offices in the United States, Latin America and Europe.
  • Represented Rizvi Traverse Management in the sale of music rights organization SESAC to funds affiliated with Blackstone.
  • Advised a private equity firm in its $15-billion pending leveraged buyout of a publicly traded alarm monitoring services company.
  • Assisted a hedge fund in its acquisition of skilled nursing facilities in Texas.
  • Represented a private equity firm in its $300-million preferred equity investment in an international engineering firm.
  • Counseled an iconic U.S. alcoholic beverages company owned by a private investor in its sale to a consortium of strategic and financial buyers.
  • Served as counsel to the senior noteholders of a bankrupt chemicals manufacturer in a debt-for-equity swap pursuant to a chapter 11 reorganization.
  • Advised a global insurance company in the $500-million disposition of its Canadian brokerage unit.
  • Assisted a controlled public company in its acquisition of three Latin American television networks.

List may include matters worked on prior to joining Akin.

Education
  • J.D., University of Pennsylvania Law School, magna cum laude, 2011

  • B.A., Johns Hopkins University, with honors, 2008

Bar Admissions
  • New York

Insights and Achievements

      News | Press Releases

      January 3, 2024

      Read More

          News | Press Releases

          January 3, 2024

          Read More

          Related Content

          People

          Distinguished by our areas of focus, as a cohesive and integrated firm, we are defined by the caliber of our work, the responsiveness of our service and a culture that is rooted in collaboration and forward-thinking.

          We Also Recommend

          Loading...
          Loading...
          Loading...
          Loading...